Please click on the ID to see detailed information about each entry.
The total number entries retrieved from this search areID1002 | SequenceAAPV | NameAAPV | Nature of peptide or cargoIt fits the P-P1 subsites of elastase and inhibits HNE competitively | AssayFranz diffusion cell, HPLC | Tissue permeabilityEpidermal flux=0.46 μg/cm2/h, Permeability coefficient=1.50×10−4Kp(cm/h) | Tissue SampleHuman epidermal membranes were obtained by heat separation of whole skin | PUBMED ID24842663 |
ID1003 | SequenceAAPV | NameC6(D)-Laa-AAPV | Nature of peptide or cargoIt fits the P-P1 subsites of elastase and inhibits HNE competitively | AssayFranz diffusion cell, HPLC | Tissue permeabilityEpidermal flux=2.29 μg/cm2/h, Permeability coefficient=7.6×10−4 Kp(cm/h) | Tissue SampleHuman epidermal membranes were obtained by heat separation of whole skin | PUBMED ID24842663 |
ID1004 | SequenceAAPV | NameC6(L)-Laa- AAPV | Nature of peptide or cargoIt fits the P-P1 subsites of elastase and inhibits HNE competitively | AssayFranz diffusion cell, HPLC | Tissue permeabilityEpidermal flux=0.50 μg/cm2/h, Permeability coefficient=1.6×10−4 Kp(cm/h) | Tissue SampleHuman epidermal membranes were obtained by heat separation of whole skin | PUBMED ID24842663 |
ID1005 | SequenceAAPV | NameC8(D,L)-Laa-AAPV | Nature of peptide or cargoIt fits the P-P1 subsites of elastase and inhibits HNE competitively | AssayFranz diffusion cell, HPLC | Tissue permeabilityEpidermal flux=10.08 μg/cm2/h, Permeability coefficient= 3.3×10−3 Kp(cm/h) | Tissue SampleHuman epidermal membranes were obtained by heat separation of whole skin | PUBMED ID24842663 |
ID1006 | SequenceAAPV | NameC8(D)-Laa-AAPV | Nature of peptide or cargoIt fits the P-P1 subsites of elastase and inhibits HNE competitively | AssayFranz diffusion cell, HPLC | Tissue permeabilityEpidermal flux=7.42 μg/cm2/h, Permeability coefficient=1.90×10−2 Kp(cm/h) | Tissue SampleHuman epidermal membranes were obtained by heat separation of whole skin | PUBMED ID24842663 |
ID1007 | SequenceAAPV | NameC8(L)-Laa-AAPV | Nature of peptide or cargoIt fits the P-P1 subsites of elastase and inhibits HNE competitively | AssayFranz diffusion cell, HPLC | Tissue permeabilityEpidermal flux=1.37 μg/cm2/h, Permeability coefficient=4.50×10−4 Kp(cm/h) | Tissue SampleHuman epidermal membranes were obtained by heat separation of whole skin | PUBMED ID24842663 |
ID1008 | SequenceAAPV | NameC10(D,L)-Laa-AAPV | Nature of peptide or cargoIt fits the P-P1 subsites of elastase and inhibits HNE competitively | AssayFranz diffusion cell, HPLC | Tissue permeabilityEpidermal flux=8.92 μg/cm2/h, Permeability coefficient=2.9×10−3 Kp(cm/h) | Tissue SampleHuman epidermal membranes were obtained by heat separation of whole skin | PUBMED ID24842663 |
ID1010 | SequenceGKRR | NameR4 (arginine-terminated peptide dendrimers) | Nature of peptide or cargoPeptide dendrimers are wedge-like molecules comprising an amino acid branching core that is most typically decorated with various basic amino acids (e.g. Lys, His, Arg) on their head groups | AssayFranz diffusion cell | Tissue permeabilityFlux (mg/cm2/h) 25.16 ± 2.31 , Q48 (mg) 1167.05 ± 50.10 Drug content in skin (mg/cm2) 146 ± 6.44 | Tissue SampleHuman epidermal skin | PUBMED ID24134794 |
ID1011 | SequenceGKRR | NameR4 (arginine-terminated peptide dendrimers) | Nature of peptide or cargoPeptide dendrimers are wedge-like molecules comprising an amino acid branching core that is most typically decorated with various basic amino acids (e.g. Lys, His, Arg) on their head groups | AssayFranz diffusion cell | Tissue permeabilityFlux (mg/cm2/h) 43.74 ± 4.15 , Q48(mg) 2064.72 ± 100.05 Drug content in skin (mg/cm2) 180 ± 8.23 | Tissue SampleHuman epidermal skin | PUBMED ID24134794 |
ID1012 | SequenceGKRR | NameR4 (arginine-terminated peptide dendrimers) | Nature of peptide or cargoPeptide dendrimers are wedge-like molecules comprising an amino acid branching core that is most typically decorated with various basic amino acids (e.g. Lys, His, Arg) on their head groups | AssayFranz diffusion cell | Tissue permeabilityFlux (mg/cm2/h) 57.66 ± 4.83 , Q48(mg) 2706.53 ± 123.60, Drug content in skin (mg/cm2) 204 ± 8.41 | Tissue SampleHuman epidermal skin | PUBMED ID24134794 |
ID1028 | Sequenceβ-Ala-H | NameL -carnosine | Nature of peptide or cargoAntioxidant | AssayFranz diffusion cell, HPLC | Tissue permeability~0.5% of applied dose | Tissue SampleStratum corneum of human breast skin | PUBMED ID22890441 |
ID1029 | Sequenceβ-Ala-H | NameL -carnosine | Nature of peptide or cargoAntioxidant | AssayFranz diffusion cell, HPLC | Tissue permeability>0.5% of applied dose | Tissue SampleStratum corneum of human breast skin | PUBMED ID22890441 |
ID1030 | Sequenceβ-Ala-H | NameL -carnosine | Nature of peptide or cargoAntioxidant | AssayFranz diffusion cell, HPLC | Tissue permeability>1% of applied dose | Tissue SampleStratum corneum of human breast skin | PUBMED ID22890441 |
ID1031 | Sequenceβ-Ala-H | NameL -carnosine | Nature of peptide or cargoAntioxidant | AssayFranz diffusion cell, HPLC | Tissue permeability<0.5% of applied dose | Tissue SampleStratum corneum of human breast skin | PUBMED ID22890441 |
ID1032 | Sequenceβ-Ala-H | NameL -carnosine | Nature of peptide or cargoAntioxidant | AssayFranz diffusion cell, HPLC | Tissue permeability<0.5% of applied dose | Tissue SampleStratum corneum of human breast skin | PUBMED ID22890441 |
ID1033 | Sequenceβ-Ala-H | NameL -carnosine | Nature of peptide or cargoAntioxidant | AssayFranz diffusion cell, HPLC | Tissue permeability>1.5% of applied dose | Tissue SampleEpidermis of human breast skin | PUBMED ID22890441 |
ID1034 | Sequenceβ-Ala-H | NameL -carnosine | Nature of peptide or cargoAntioxidant | AssayFranz diffusion cell, HPLC | Tissue permeability~2% of applied dose | Tissue SampleEpidermis of human breast skin | PUBMED ID22890441 |
ID1035 | Sequenceβ-Ala-H | NameL -carnosine | Nature of peptide or cargoAntioxidant | AssayFranz diffusion cell, HPLC | Tissue permeability<4% of applied dose | Tissue SampleEpidermis of human breast skin | PUBMED ID22890441 |
ID1036 | Sequenceβ-Ala-H | NameL -carnosine | Nature of peptide or cargoAntioxidant | AssayFranz diffusion cell, HPLC | Tissue permeability~0.5% of applied dose | Tissue SampleEpidermis of human breast skin | PUBMED ID22890441 |
ID1037 | Sequenceβ-Ala-H | NameL -carnosine | Nature of peptide or cargoAntioxidant | AssayFranz diffusion cell, HPLC | Tissue permeability<1% of applied dose | Tissue SampleEpidermis of human breast skin | PUBMED ID22890441 |
ID1038 | Sequenceβ-Ala-H | NameL -carnosine | Nature of peptide or cargoAntioxidant | AssayFranz diffusion cell, HPLC | Tissue permeability>8% of applied dose | Tissue SampleDermis of human breast skin | PUBMED ID22890441 |
ID1039 | Sequenceβ-Ala-H | NameL -carnosine | Nature of peptide or cargoAntioxidant | AssayFranz diffusion cell, HPLC | Tissue permeability<4% of applied dose | Tissue SampleDermis of human breast skin | PUBMED ID22890441 |
ID1040 | Sequenceβ-Ala-H | NameL -carnosine | Nature of peptide or cargoAntioxidant | AssayFranz diffusion cell, HPLC | Tissue permeability<18% of applied dose | Tissue SampleDermis of human breast skin | PUBMED ID22890441 |
ID1041 | Sequenceβ-Ala-H | NameL -carnosine | Nature of peptide or cargoAntioxidant | AssayFranz diffusion cell, HPLC | Tissue permeability~3% of applied dose | Tissue SampleDermis of human breast skin | PUBMED ID22890441 |
ID1042 | Sequenceβ-Ala-H | NameL -carnosine | Nature of peptide or cargoAntioxidant | AssayFranz diffusion cell, HPLC | Tissue permeability>8% of applied dose | Tissue SampleDermis of human breast skin | PUBMED ID22890441 |
ID1043 | Sequenceβ-Ala-H | NameN-acetyl- L -carnosine | Nature of peptide or cargoAntioxidant | AssayFranz diffusion cell, HPLC | Tissue permeability>5% of applied dose | Tissue SampleStratum corneum of human breast skin | PUBMED ID22890441 |
ID1044 | Sequenceβ-Ala-H | NameN-acetyl- L -carnosine | Nature of peptide or cargoAntioxidant | AssayFranz diffusion cell, HPLC | Tissue permeability~6% of applied dose | Tissue SampleStratum corneum of human breast skin | PUBMED ID22890441 |
ID1045 | Sequenceβ-Ala-H | NameN-acetyl- L -carnosine | Nature of peptide or cargoAntioxidant | AssayFranz diffusion cell, HPLC | Tissue permeability~1.5% of applied dose | Tissue SampleStratum corneum of human breast skin | PUBMED ID22890441 |
ID1046 | Sequenceβ-Ala-H | NameN-acetyl- L -carnosine | Nature of peptide or cargoAntioxidant | AssayFranz diffusion cell, HPLC | Tissue permeability~5% of applied dose | Tissue SampleStratum corneum of human breast skin | PUBMED ID22890441 |
ID1047 | Sequenceβ-Ala-H | NameN-acetyl- L -carnosine | Nature of peptide or cargoAntioxidant | AssayFranz diffusion cell, HPLC | Tissue permeability~3% of applied dose | Tissue SampleStratum corneum of human breast skin | PUBMED ID22890441 |
ID1048 | Sequenceβ-Ala-H | NameN-acetyl- L -carnosine | Nature of peptide or cargoAntioxidant | AssayFranz diffusion cell, HPLC | Tissue permeability~2% of applied dose | Tissue SampleStratum corneum of human breast skin | PUBMED ID22890441 |
ID1049 | Sequenceβ-Ala-H | NameN-acetyl- L -carnosine | Nature of peptide or cargoAntioxidant | AssayFranz diffusion cell, HPLC | Tissue permeability~7% of applied dose | Tissue SampleStratum corneum of human breast skin | PUBMED ID22890441 |
ID1050 | Sequenceβ-Ala-H | NameN-acetyl- L -carnosine | Nature of peptide or cargoAntioxidant | AssayFranz diffusion cell, HPLC | Tissue permeability~3% of applied dose | Tissue SampleStratum corneum of human breast skin | PUBMED ID22890441 |
ID1051 | Sequenceβ-Ala-H | NameN-acetyl- L -carnosine | Nature of peptide or cargoAntioxidant | AssayFranz diffusion cell, HPLC | Tissue permeability2% of applied dose | Tissue SampleStratum corneum of human breast skin | PUBMED ID22890441 |
ID1052 | Sequenceβ-Ala-H | NameN-acetyl- L -carnosine | Nature of peptide or cargoAntioxidant | AssayFranz diffusion cell, HPLC | Tissue permeability~11% of applied dose | Tissue SampleEpidermis of human breast skin | PUBMED ID22890441 |
ID1053 | Sequenceβ-Ala-H | NameN-acetyl- L -carnosine | Nature of peptide or cargoAntioxidant | AssayFranz diffusion cell, HPLC | Tissue permeability~9% of applied dose | Tissue SampleEpidermis of human breast skin | PUBMED ID22890441 |
ID1054 | Sequenceβ-Ala-H | NameN-acetyl- L -carnosine | Nature of peptide or cargoAntioxidant | AssayFranz diffusion cell, HPLC | Tissue permeability~3% of applied dose | Tissue SampleEpidermis of human breast skin | PUBMED ID22890441 |
ID1055 | Sequenceβ-Ala-H | NameN-acetyl- L -carnosine | Nature of peptide or cargoAntioxidant | AssayFranz diffusion cell, HPLC | Tissue permeability~10% of applied dose | Tissue SampleEpidermis of human breast skin | PUBMED ID22890441 |
ID1056 | Sequenceβ-Ala-H | NameN-acetyl- L -carnosine | Nature of peptide or cargoAntioxidant | AssayFranz diffusion cell, HPLC | Tissue permeability~7% of applied dose | Tissue SampleEpidermis of human breast skin | PUBMED ID22890441 |
ID1057 | Sequenceβ-Ala-H | NameN-acetyl- L -carnosine | Nature of peptide or cargoAntioxidant | AssayFranz diffusion cell, HPLC | Tissue permeability~5% of applied dose | Tissue SampleEpidermis of human breast skin | PUBMED ID22890441 |
ID1058 | Sequenceβ-Ala-H | NameN-acetyl- L -carnosine | Nature of peptide or cargoAntioxidant | AssayFranz diffusion cell, HPLC | Tissue permeability~12% of applied dose | Tissue SampleEpidermis of human breast skin | PUBMED ID22890441 |
ID1059 | Sequenceβ-Ala-H | NameN-acetyl- L -carnosine | Nature of peptide or cargoAntioxidant | AssayFranz diffusion cell, HPLC | Tissue permeability>4% of applied dose | Tissue SampleEpidermis of human breast skin | PUBMED ID22890441 |
ID1060 | Sequenceβ-Ala-H | NameN-acetyl- L -carnosine | Nature of peptide or cargoAntioxidant | AssayFranz diffusion cell, HPLC | Tissue permeability~4% of applied dose | Tissue SampleEpidermis of human breast skin | PUBMED ID22890441 |
ID1061 | Sequenceβ-Ala-H | NameN-acetyl- L -carnosine | Nature of peptide or cargoAntioxidant | AssayFranz diffusion cell, HPLC | Tissue permeability>36% of applied dose | Tissue SampleDermis of human breast skin | PUBMED ID22890441 |
ID1062 | Sequenceβ-Ala-H | NameN-acetyl- L -carnosine | Nature of peptide or cargoAntioxidant | AssayFranz diffusion cell, HPLC | Tissue permeability>26% of applied dose | Tissue SampleDermis of human breast skin | PUBMED ID22890441 |
ID1063 | Sequenceβ-Ala-H | NameN-acetyl- L -carnosine | Nature of peptide or cargoAntioxidant | AssayFranz diffusion cell, HPLC | Tissue permeability~26% of applied dose | Tissue SampleDermis of human breast skin | PUBMED ID22890441 |
ID1064 | Sequenceβ-Ala-H | NameN-acetyl- L -carnosine | Nature of peptide or cargoAntioxidant | AssayFranz diffusion cell, HPLC | Tissue permeability25% of applied dose | Tissue SampleDermis of human breast skin | PUBMED ID22890441 |
ID1065 | Sequenceβ-Ala-H | NameN-acetyl- L -carnosine | Nature of peptide or cargoAntioxidant | AssayFranz diffusion cell, HPLC | Tissue permeability20% of applied dose | Tissue SampleDermis of human breast skin | PUBMED ID22890441 |
ID1066 | Sequenceβ-Ala-H | NameN-acetyl- L -carnosine | Nature of peptide or cargoAntioxidant | AssayFranz diffusion cell, HPLC | Tissue permeability~20% of applied dose | Tissue SampleDermis of human breast skin | PUBMED ID22890441 |
ID1067 | Sequenceβ-Ala-H | NameN-acetyl- L -carnosine | Nature of peptide or cargoAntioxidant | AssayFranz diffusion cell, HPLC | Tissue permeability~26% of applied dose | Tissue SampleDermis of human breast skin | PUBMED ID22890441 |